Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond
Several challenges need to be addressed when developing viruses for clinical applications in gene therapy, vaccination, or viral oncolysis, including specific and efficient target cell transduction, virus delivery via the blood stream, and evasion of pre-existing immunity. With rising frequency, the...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
24 May 2012
|
| In: |
Trends in molecular medicine
Year: 2012, Volume: 18, Issue: 7, Pages: 365-376 |
| ISSN: | 1471-499X |
| DOI: | 10.1016/j.molmed.2012.04.008 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/j.molmed.2012.04.008 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1471491412000718 
|
| Author Notes: | Johanna K. Kaufmann, Dirk M. Nettelbeck |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1577743520 | ||
| 003 | DE-627 | ||
| 005 | 20230426230708.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180719s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.molmed.2012.04.008 |2 doi | |
| 035 | |a (DE-627)1577743520 | ||
| 035 | |a (DE-576)507743520 | ||
| 035 | |a (DE-599)BSZ507743520 | ||
| 035 | |a (OCoLC)1341014029 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kaufmann, Johanna K. |e VerfasserIn |0 (DE-588)1036151905 |0 (DE-627)749727764 |0 (DE-576)383684714 |4 aut | |
| 245 | 1 | 0 | |a Virus chimeras for gene therapy, vaccination, and oncolysis |b adenoviruses and beyond |c Johanna K. Kaufmann, Dirk M. Nettelbeck |
| 264 | 1 | |c 24 May 2012 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.07.2018 | ||
| 520 | |a Several challenges need to be addressed when developing viruses for clinical applications in gene therapy, vaccination, or viral oncolysis, including specific and efficient target cell transduction, virus delivery via the blood stream, and evasion of pre-existing immunity. With rising frequency, these goals are tackled by generating chimeric viruses containing nucleic acid fragments or proteins from two or more different viruses, thus combining different beneficial features of the parental viruses. These chimeras have boosted the development of virus-based treatment regimens for major inherited and acquired diseases, including cancer. Using adenoviruses as the paradigm and prominent examples from other virus families, we review the technological and functional advances in therapeutic virus chimera development and recent successful applications that can pave the way for future therapies. | ||
| 650 | 4 | |a adenovirus | |
| 650 | 4 | |a chimeric virus | |
| 650 | 4 | |a gene delivery | |
| 650 | 4 | |a gene transfer vector | |
| 650 | 4 | |a oncolytic virus | |
| 650 | 4 | |a viral tropism | |
| 650 | 4 | |a virus capsid | |
| 700 | 1 | |a Nettelbeck, Dirk M. |d 1969- |e VerfasserIn |0 (DE-588)122239040 |0 (DE-627)705825671 |0 (DE-576)293167346 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Trends in molecular medicine |d Amsterdam [u.a.] : Elsevier Science, 2001 |g 18(2012), 7, Seite 365-376 |h Online-Ressource |w (DE-627)391368036 |w (DE-600)2155736-6 |w (DE-576)252209338 |x 1471-499X |7 nnas |a Virus chimeras for gene therapy, vaccination, and oncolysis adenoviruses and beyond |
| 773 | 1 | 8 | |g volume:18 |g year:2012 |g number:7 |g pages:365-376 |g extent:12 |a Virus chimeras for gene therapy, vaccination, and oncolysis adenoviruses and beyond |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.molmed.2012.04.008 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1471491412000718 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180719 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 122239040 |a Nettelbeck, Dirk M. |m 122239040:Nettelbeck, Dirk M. |d 50000 |e 50000PN122239040 |k 0/50000/ |p 2 |y j | ||
| 998 | |g 1036151905 |a Kaufmann, Johanna K. |m 1036151905:Kaufmann, Johanna K. |d 910000 |d 911300 |e 910000PK1036151905 |e 911300PK1036151905 |k 0/910000/ |k 1/910000/911300/ |p 1 |x j | ||
| 999 | |a KXP-PPN1577743520 |e 3018301013 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"part":{"issue":"7","pages":"365-376","year":"2012","extent":"12","volume":"18","text":"18(2012), 7, Seite 365-376"},"pubHistory":["7.2001 -"],"recId":"391368036","language":["eng"],"disp":"Virus chimeras for gene therapy, vaccination, and oncolysis adenoviruses and beyondTrends in molecular medicine","note":["Gesehen am 21.11.23"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Trends in molecular medicine","title_sort":"Trends in molecular medicine"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1471-499X"],"eki":["391368036"],"zdb":["2155736-6"]},"origin":[{"dateIssuedKey":"2001","publisher":"Elsevier Science","dateIssuedDisp":"2001-","publisherPlace":"Amsterdam [u.a.]"}]}],"physDesc":[{"extent":"12 S."}],"id":{"eki":["1577743520"],"doi":["10.1016/j.molmed.2012.04.008"]},"origin":[{"dateIssuedDisp":"24 May 2012","dateIssuedKey":"2012"}],"name":{"displayForm":["Johanna K. Kaufmann, Dirk M. Nettelbeck"]},"recId":"1577743520","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 19.07.2018"],"title":[{"title_sort":"Virus chimeras for gene therapy, vaccination, and oncolysis","subtitle":"adenoviruses and beyond","title":"Virus chimeras for gene therapy, vaccination, and oncolysis"}],"person":[{"given":"Johanna K.","family":"Kaufmann","role":"aut","roleDisplay":"VerfasserIn","display":"Kaufmann, Johanna K."},{"role":"aut","display":"Nettelbeck, Dirk M.","roleDisplay":"VerfasserIn","given":"Dirk M.","family":"Nettelbeck"}]} | ||
| SRT | |a KAUFMANNJOVIRUSCHIME2420 | ||